Galapagos N.V. Stock
Galapagos N.V. Stock
A loss of -2.190% shows a downward development for Galapagos N.V..
The community is currently still undecided about Galapagos N.V. with 1 Buy predictions and 0 Sell predictions.
As a result the target price of 36 € shows a positive potential of 32.65% compared to the current price of 27.14 € for Galapagos N.V..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Galapagos N.V. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Galapagos N.V. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Galapagos N.V. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Galapagos N.V. | -2.190% | 1.193% | -7.435% | -25.234% | -26.728% | -58.220% | - |
Medpace Holdings Inc | 1.180% | 0.523% | -0.164% | 96.344% | 29.964% | 160.857% | - |
Sage Therapeutics Inc. | -3.520% | 1.448% | -19.076% | -68.390% | -35.200% | -80.196% | - |
Ironwood Pharmaceuticals | -1.300% | 4.054% | 1.987% | -18.085% | -24.510% | -15.847% | - |